Phase-IV Clinical Evaluation
Published in
Evaluation of the safety and effectiveness of intradermal administration of QR678® anti-hair loss formulation - A phase-IV, open-label, single-arm multi-ethnicity clinical trial
- Background and Scientific Context
Clinical documentation of hair thinning and increased hair shedding remains an important component of dermatology practice, particularly in patients presenting with patterned hair changes and other reasons for hair thinning encountered in routine clinics. Evaluation commonly involves serial assessment of scalp condition, follicular appearance, and changes observed across successive visits, interpreted within established hair cycle phases and known variability in hair biology.
This multicentric Phase IV study documents hair and scalp parameters observed following intradermal scalp application of a proprietary formulation, QR678, in adults presenting with patterned hair thinning. The investigation focuses on structured clinical assessments performed under routine practice conditions, contributing observational data related to hair and scalp characteristics and the broader scalp environment recorded over the study period.
This multicentric Phase IV study documents hair and scalp parameters observed following intradermal scalp application of a proprietary formulation, QR678, in adults presenting with patterned hair thinning. The investigation focuses on structured clinical assessments performed under routine practice conditions, contributing observational data related to hair and scalp characteristics and the broader scalp environment recorded over the study period.
- Study Design and Experimental Framework
The study was conducted as a multicentric, open-label Phase IV clinical investigation across dermatology clinics in multiple geographic regions. Adult participants between 18 and 65 years of age presenting with patterned hair thinning were enrolled based on predefined inclusion criteria.
The protocol involved intradermal scalp application administered at fixed intervals under clinical supervision. The study did not include randomization, placebo control, or comparator arms. While the original trial design was interventional, the documentation presented here is limited to clinical observation and does not infer therapeutic outcomes.
The protocol involved intradermal scalp application administered at fixed intervals under clinical supervision. The study did not include randomization, placebo control, or comparator arms. While the original trial design was interventional, the documentation presented here is limited to clinical observation and does not infer therapeutic outcomes.
- Hair and Scalp Assessment Methods
Participants underwent structured evaluations at baseline and at scheduled follow-up visits. Assessment tools included clinical scalp examination, hair pull testing as a clinical indicator used in differentiating hair shedding vs hair fall, global photographic documentation under standardized conditions, and videomicroscopic evaluation of hair and scalp parameters.
Participant-reported feedback related to procedural experience and scalp sensations was recorded using standardized questionnaires. All assessment methods reflect commonly employed dermatological documentation techniques rather than efficacy-driven outcome measures.
Participant-reported feedback related to procedural experience and scalp sensations was recorded using standardized questionnaires. All assessment methods reflect commonly employed dermatological documentation techniques rather than efficacy-driven outcome measures.
- Observational Findings and Hair Cycle Considerations
Clinical observations were interpreted within established frameworks of hair biology and hair cycle phases. Documentation focused on changes noted during repeated assessments, without assigning causality, permanence, or predictive value to the findings.
The study did not attempt to categorize observations under disease-specific mechanisms or consumer-oriented distinctions beyond descriptive recording. All findings were documented in alignment with routine dermatological evaluation practices.
The study did not attempt to categorize observations under disease-specific mechanisms or consumer-oriented distinctions beyond descriptive recording. All findings were documented in alignment with routine dermatological evaluation practices.
- Tolerability and Safety Observations
Tolerability was monitored throughout the study period. Observations were primarily localized and transient, including mild procedural discomfort or temporary scalp sensitivity associated with intradermal application.
No systemic adverse events were documented during the study timeframe. Safety-related observations were recorded descriptively and without extrapolation beyond the duration of clinical follow-up.
No systemic adverse events were documented during the study timeframe. Safety-related observations were recorded descriptively and without extrapolation beyond the duration of clinical follow-up.
- Scope, Limitations, and Research Relevance
As a Phase IV clinical investigation without control groups or blinding, the study is subject to inherent methodological limitations. It does not establish causal relationships, comparative effectiveness, or long-term outcomes.
Within these constraints, the study contributes large-scale clinical documentation of hair and scalp parameters observed across diverse patient populations under routine dermatological use. The findings serve as reference material for clinicians and researchers and may inform the design of future controlled studies focused on scalp and follicular assessment.
Within these constraints, the study contributes large-scale clinical documentation of hair and scalp parameters observed across diverse patient populations under routine dermatological use. The findings serve as reference material for clinicians and researchers and may inform the design of future controlled studies focused on scalp and follicular assessment.
- Disclaimer
QR678® is marketed as a cosmetic formulation in many countries and does not claim to diagnose, treat, cure, prevent, restore, or regrow hair. The research papers and clinical articles referenced on this website are peer-reviewed scientific publications authored by qualified medical professionals and represent the observations and conclusions of the respective authors, based on their individual clinical research.
These clinical references are provided for informational and educational purposes and should not be interpreted as promotional claims or outcome guarantees by or QR678®. Consumers are advised to consult a qualified healthcare professional for medical interpretation or hair- or scalp-related concerns.
